clinical process and outcome, and the network is now prioritising work with managers and patients to support future redesign.
BACKGROUND

Outline of problem
The rising incidence and prevalence of diabetes presents a growing challenge to health services internationally. 1 Systematically implementing national diabetes guidelines 2 is difficult though, because it requires clinical care and quality improvement to be co-ordinated across existing health service and disciplinary boundaries. In the UK, National Service
Frameworks provide additional guidance on how clinical guidelines can be delivered, and recommend the creation of clinical networks with responsibility for all diabetes care in an area. [3] [4] [5] [6] [7] However, there is little reported evidence as to how networks should be organised or their effectiveness. 8 9 This paper describes the form and impact of quality improvement work in the Tayside Diabetes Managed Clinical Network (TDMCN), which has previously been identified as a model for UK diabetes services.
10
Outline of the context
The Tayside Region of Scotland has a population of ~385,000, and includes deprived urban areas, small towns, and remote, rural areas. Primary healthcare is provided by 72 general practices, with specialist diabetes services delivered from three sites (a teaching hospital diabetes centre, and two district general hospitals), plus outreach clinics in small towns distant from these. The number of people with diabetes in the region increased by ~50%
between January 1998 and January 2005, from 8,846 (2.3% prevalence) to 13,527 (3.5%). Professionals were purposively sampled from MCN committees, and from general practices that were high and low users of the MCN website. We were unable to identify high and low website users reliably in hospital settings and so used snowballing techniques to recruit hospital professionals with variable levels of commitment to the MCN. People with diabetes were sampled from high and low web-using general practices, but initial analysis indicated that they had little knowledge of the MCN as an organisation. We therefore instead recruited lay representatives on MCN committees to explore the perspectives of informed patients (Table 2) . Semi-structured interview schedules were used and lasted 30-70 minutes, and were taped and transcribed. 
ASSESSMENT OF PROBLEMS
Since the late 1990s, clinical data for all people with diabetes in Tayside has been entered into a regional register. Accuracy and completeness is maintained by the use of a unique identifier throughout NHS Tayside (the Community Health Index number), and routine data checking and correction by MCN data facilitators. In 1998, a complete audit of all people with diabetes in Tayside identified widespread deficiencies in care, with inappropriately low levels of clinical process and outcome (table 1) . This prompted widespread recognition that change was essential in both primary and secondary care. 
STRATEGIES FOR CHANGE
Quality improvement activities implemented
The working assumption from the outset was that there are no single interventions, or 'magic bullets', that are guaranteed to improve quality. 13 TDMCN therefore progressively implemented a range of complementary QI strategies, within a supportive national context that included national guidelines 14 and guidance, 4 and quality improvement orientated regulation 15 by NHS Quality Improvement Scotland 16 . Table 2 shows the scope of the QI activities undertaken by TCMCN, and when each was first implemented. Analysis drew on
Ferlie and Shortell's multilevel framework for healthcare quality improvement 17 to which network activities to reinforce shared goals and systematic care broadly map, although TDMCN predates and did not explicitly follow this, or any other QI model. Stand-alone regional register was designed for audit; DARTS/SCI-DC includes practice audit tools 19 Single shared guidelines and protocols for all professional groups disseminated via MCN website. Between 1998 and 2005, TDMCN primarily encouraged systematic, guideline-driven care by focusing on changing the clinical practice of individual professionals and small, multidisciplinary teams. Areas of activity identified by participants as key are briefly described below (more detailed information can be found on the network website 19 ).
a) Guidelines, protocol, pathway implementation National guidelines were locally modified to create the Tayside Diabetes Handbook, available in both paper and electronic form. Matching patient information leaflets were created and made available electronically, combining information about both diabetes and services available. Guideline implementation was achieved primarily through audit, feedback, and professional education, focusing on changing routine clinical practice, supplemented where necessary with task redesign. Between 1998 and 2002, the emphasis was on ensuring that key care processes and outcomes were delivered, with less attention paid to ensuring that only patients needing specialist care attended hospital. In 2002, a new care pathway was defined by a multi-disciplinary working group, which clearly identified when primary or specialist care was appropriate for people with type-2 diabetes. 20 Implementation was monitored through changes in the proportion of people with type-2 diabetes attending hospital.
b) Education
Professional education has been tailored to varying levels of clinician interest, from localitybased multi-disciplinary diabetes forums where educational form and content were determined by participants, through development of a local MSc level module, to sponsorship for professionals to undertake an intensive course in diabetes management. improved over the whole period with shifts to routine use of monofilaments for foot examination, and to all retinal screening now being by quality-assured digital photography).
Process measures for people with type-2 diabetes have improved more than for those with type-1.
Interpretation of intermediate outcome data should be cautious, since significant numbers of patients were not regularly screened in the early years. Since unscreened patients are likely to have worse control, engaging more patients in care may initially lead to worse measured outcomes. 24 For people with type-2 diabetes, mean systolic and diastolic blood pressure and cholesterol are significantly lower. Glycaemic control worsened in the first three years but has shown improvement since. For people with type-1 diabetes, intermediate outcomes are
only improved for cholesterol control (although again, glycaemic control worsened in the early years of the network, and has been improving since). Table 5 compares process quality in Tayside (table 6) . However, because of rising prevalence the total numbers of patients with type-2 diabetes being treated in hospital remained unchanged, despite an additional 3191 patients being exclusively treated in primary care (a 66.2% increase). There has been a major shift to primary care for people with type-2 diabetes. However, because of static resources in the face of rising prevalence, hospital clinics continue to work at capacity which has prevented full implementation of the redesigned care pathway.
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Next steps
Participants in the evaluation identified three weaknesses of the initial TDMCN model, which are currently being addressed by the network. First, the initial emphasis was overwhelmingly on professional engagement, reflecting QI frameworks and service organisation at the time. 17 Since 2003/4, the network has actively increased patients' involvement in network planning and in their own care, notably through redesign of patient education, implementing automatic production of individualised patient information from the web-based clinical record, and creating a patient portal. This reflects growing appreciation of the potential for patient and public involvement to improve quality of care. 25 26 Second, the professionals initially engaged by the network were predominately clinicians, with less attention paid to NHS management.
This proved limiting when additional resources were required to fully implement care pathway redesign in the face of rapidly rising prevalence. Recent more active network collaboration with NHS management has led to Health Board investment to facilitate fuller implementation of the new care pathway. Finally, type-2 diabetes care was initially prioritised, which is reflected in slower improvement in quality of care for people with type-1 diabetes. Type-1 diabetes is now a network and national 21 priority, although quality improvement will at least partly depend on the ability of the network to free specialist resource by shifting an even greater proportion of routine type-2 diabetes care into primary care. The impact of these next steps will be the subject of future evaluation.
Wider implications
To the best of our knowledge, this is the first systematic, independent evaluation of a managed clinical network anywhere in the UK where patient outcomes have been studied. 17 TDMCN implemented and sustained QI activity at all levels of the system of care. Although participants said that they could not easily identify which QI intervention had had the most impact, they did highlight the central role of information technology in supporting QI.
However, participants were clear that IT alone did not change practice. More important was the way in which TDMCN successfully engaged clinicians across the region and across professional boundaries, persuading them to commit to improving quality of care for increasing numbers of people with diabetes without significant additional resources. One significant driver for this was the provision of a range of educational interventions, but the key facilitator was network leadership by enthusiastic clinicians, with a clear vision for an effective and equitable system of diabetes care, and a commitment to collaboration demonstrated by leadership being shared between specialists and general practitioners.
Although the generalisability of networks remains uncertain, TDMCN's experience therefore shows the potential of diabetes clinical networks to engage with clinicians across whole systems and deliver changes in professional practice and better patient care by deploying an appropriate range of IT-facilitated QI activities.
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